BAIT

BCL2L13

BCL-RAMBO, Bcl2-L-13, MIL1, CD003
BCL2-like 13 (apoptosis facilitator)
GO Process (2)
GO Function (1)
GO Component (2)
Homo sapiens
PREY

CDK5R1

CDK5P35, CDK5R, NCK5A, p23, p25, p35, p35nck5a
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
Homo sapiens

Two-hybrid

Bait protein expressed as a DNA binding domain (DBD) fusion and prey expressed as a transcriptional activation domain (TAD) fusion and interaction measured by reporter gene activation.

Publication

Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.

Jensen SA, Calvert AE, Volpert G, Kouri FM, Hurley LA, Luciano JP, Wu Y, Chalastanis A, Futerman AH, Stegh AH

Therapy resistance is a major limitation to the successful treatment of cancer. Here, we identify Bcl2-like 13 (Bcl2L13), an atypical member of the Bcl-2 family, as a therapy susceptibility gene with elevated expression in solid and blood cancers, including glioblastoma (GBM). We demonstrate that mitochondria-associated Bcl2L13 inhibits apoptosis induced by a wide spectrum of chemo- and targeted therapies upstream of ... [more]

Proc Natl Acad Sci U S A Apr. 15, 2014; 111(15);5682-7 [Pubmed: 24706805]

Throughput

  • Low Throughput

Curated By

  • BioGRID